<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03186547</url>
  </required_header>
  <id_info>
    <org_study_id>CEBD-CU-2017-06-02</org_study_id>
    <nct_id>NCT03186547</nct_id>
  </id_info>
  <brief_title>Satisfaction Of Adult Patients With Gummy Smile Treated By Botulinum Toxin A Injection</brief_title>
  <official_title>Satisfaction Of Adult Patients With Gummy Smile Treated By Botulinum Toxin A Injection Versus Modified Lip Repositioning Surgery : A Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the proposal study is to answer the question of how to manage gummy smiles due to
      hypermobile upper lip with less invasive and low risk level procedure . This trial will help
      the practitioners and the patients in taking the convenient decision to correct the gumminess
      to restore lip-gingival-dental harmony and enhance smile asthetics.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this randomized clinical trial , two groups will be included to compare the effectiveness
      of a treatment modality of botulinum toxin-A injection , in the first group , on gingival
      display during smiling ,patient satisfaction , lower face esthetics ( upper lip length ,
      upper lip vermillion length , interlabial gap , nasolabial angle) and the postoperative side
      effects . the comparator group will receive treatment by modified lip repositioning surgery
      ,to compare the results of the intervention group that can possibly obtained without
      undergoing surgery.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 2017</start_date>
  <completion_date type="Anticipated">June 2018</completion_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>single blind</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Patient satisfaction and postoperative side effects</measure>
    <time_frame>at 4 weeks</time_frame>
    <description>it will be assessed using Questionnaire.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Improvement of gingival display upon smiling</measure>
    <time_frame>at 4,8 and 12 weeks</time_frame>
    <description>it will be assessed using Digital ruler on DSS software</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lower face esthatics: a) upper lip length b) upper lip- vermillion length c) interlabial gap</measure>
    <time_frame>at 4,8 and 12 weeks</time_frame>
    <description>it will be assessed using Digital ruler and angle measurement on DSS software</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lower face esthatics: d)nasolabial angle</measure>
    <time_frame>at 4,8 and 12 weeks</time_frame>
    <description>it will be assessed using Digital angle measurement on DSS software</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>stability of gummy smile correction.</measure>
    <time_frame>at the end of 24 weeks.</time_frame>
    <description>it will be assessed using Digital ruler on DSS software</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">22</enrollment>
  <condition>Gummy Smile Due to Hypermobile Upper Lip</condition>
  <arm_group>
    <arm_group_label>Botulinum Toxin A Injection</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>this group will receive Botulinum Toxin A Injection at doses of 2.5 or 5 IU (depending on the degree of gum exposure) on each side of the nasolabial fold with follow up at at 2,4,8,12 and 24 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Modified Lip Repositioning Surgery</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>this group will receive Modified Lip Repositioning Surgery with follow up at at 2,4,8,12 and 24 weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Botulinum Toxin A Injection</intervention_name>
    <description>adult patients with gummy smile due to hypermobile upper lip will receive Botulinum Toxin A Injection with a single injection1 cm lateral to the ala horizontally and 3 cm above the lip line vertically.</description>
    <arm_group_label>Botulinum Toxin A Injection</arm_group_label>
    <other_name>BOTOX</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Modified Lip Repositioning Surgery</intervention_name>
    <description>the surgical procedure will be done by removal of strip of epithelium by careful dissection and stabilizing the new mucosal margin to the gingiva to improve the gingival display in adult patients with gummy smile.</description>
    <arm_group_label>Modified Lip Repositioning Surgery</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adults with age range from 18 - 30 years.

          -  Excessive gingival display more than 3 mm during smiling.

          -  Patients having hypermobile upper lip with or without (mild / moderate) vertical
             maxillary excess.

          -  Patients with normal morphology of clinical crowns.

          -  Normal lip separation (ILG) at rest

          -  Medically free subjects.

        Exclusion Criteria:

          -  Patients with systemic diseases or neuromuscular disorders.

          -  Gummy smile with gingival display more than 8 mm during smiling.

          -  Severly long face (VME) patients.

          -  Patients with periodontal disease or gingival hyperplasia .

          -  Medically compromised patients contraindicated for surgery .

          -  Pregnant or lactating female patients.

          -  Patients with inadequate attached gingiva .
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 11, 2017</study_first_submitted>
  <study_first_submitted_qc>June 13, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 14, 2017</study_first_posted>
  <last_update_submitted>June 19, 2017</last_update_submitted>
  <last_update_submitted_qc>June 19, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 20, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Zeinab mohamed</investigator_full_name>
    <investigator_title>principal investigator</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Botulinum Toxins</mesh_term>
    <mesh_term>Botulinum Toxins, Type A</mesh_term>
    <mesh_term>onabotulinumtoxinA</mesh_term>
    <mesh_term>abobotulinumtoxinA</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

